CMPX vs ROK · $367.4M cap vs P/E 48, rev $8.34B
Compass Therapeutics Inc. (CMPX) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
CMPX does not have a complete income-statement cache yet.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. Revenue was up 0.9% from 2024-09-30 to 2025-09-30. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
CMPX currently screens at market cap $367.4M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the CMPX and ROK stock pages for the full models.
Not investment advice.